The FDA has been testing medications for NDMA since 2018, when drug-makers in India and China were forced to issue numerous recalls for several blood-pressure drugs that were contaminated by NDMA.

In September 2019, the FDA issued a warning after ZantacĀ® heartburn medications and generics tested positive for NDMA (N-nitrosodimethylamine).

In April 2020, the FDA pulled all remaining Zantac and ranitidine off store shelves in the U.S. due to the risk of cancer. The agency determined that levels of a cancer-causing chemical impurity (NDMA) can increase in the pills over time, or when the pills are stored above room-temperature. This means all over-the-counter and prescription-strength Zantac and ranitidine will no longer be sold in the U.S.

Send my Documents
Send my Documents

Zantac Linked to These Cancers

  • Stomach Cancer
  • Liver Cancer
  • Kidney Cancer
  • Pancreatic Cancer
  • Testicular Cancer
  • Prostate Cancer
  • Thyroid Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Throat Cancer
  • Intestinal Cancer
  • Esophageal Cancer
  • Bladder Cancer
  • Cancer in babies if the mother took Zantac while pregnant

FREE Evaluation for your Zantac Case

Justice for Zantac Victims

Send my Documents

Important:  There are strict time deadlines for filing your claim, ACT NOW